AAAAAA

   
Results: 1-15 |
Results: 15
ACUTE REACTIONS AND COSMETIC OUTCOME AFTER CONSERVATIVE SURGERY AND ADJUVANT RT IN STAGE I-II BREAST-CANCER
Authors: VALLI MC AMADORI M ASNSGHI D CATALANO G FRANCOLINI DC DEAGOSTINI A MEREGALLI S MOLTENI M PALAZZI M PERSONENI A
Citation: Mc. Valli et al., ACUTE REACTIONS AND COSMETIC OUTCOME AFTER CONSERVATIVE SURGERY AND ADJUVANT RT IN STAGE I-II BREAST-CANCER, European journal of cancer, 34, 1998, pp. 269-269
PHYSIOPATHOLOGY OF IL-12 IN HUMAN SOLID NEOPLASMS - BLOOD-LEVELS OF IL-12 IN EARLY OR ADVANCED CANCER-PATIENTS, AND THEIR VARIATIONS WITH SURGERY AND IMMUNOTHERAPY
Authors: LISSONI P MENGO S MANDALA M MAURI E BRIVIO F ROVELLI F CONFALONIERI G LONGARINI R BONFANTE A FOLLI D MEREGALLI S BARNI S TANCINI G GIANI L
Citation: P. Lissoni et al., PHYSIOPATHOLOGY OF IL-12 IN HUMAN SOLID NEOPLASMS - BLOOD-LEVELS OF IL-12 IN EARLY OR ADVANCED CANCER-PATIENTS, AND THEIR VARIATIONS WITH SURGERY AND IMMUNOTHERAPY, Journal of biological regulators and homeostatic agents, 12(1-2), 1998, pp. 38-41
CLINICAL EFFICACY OF THE AROMATASE INHIBITOR ANASTROZOLE IN RELATION TO PROLACTIN SECRETION IN HEAVILY PRETREATED METASTATIC BREAST-CANCER
Authors: BARNI S LISSONI P MEREGALLI S ARDIZZOIA A MENGO S MUSCO F MERLINI D TANCINI G
Citation: S. Barni et al., CLINICAL EFFICACY OF THE AROMATASE INHIBITOR ANASTROZOLE IN RELATION TO PROLACTIN SECRETION IN HEAVILY PRETREATED METASTATIC BREAST-CANCER, Tumori, 84(1), 1998, pp. 45-47
EFFECT OF INTERLEUKIN-12 IMMUNOTHERAPY ON ENDOGENOUS SECRETION OF INTERLEUKIN-2 IN METASTATIC CANCER-PATIENTS
Authors: LISSONI P MANDALA M ROVELLI F GIANI L BARNI S MAURI E TANCINI G FUMAGALLI L DIFELICE G MAIORCA F MEREGALLI S
Citation: P. Lissoni et al., EFFECT OF INTERLEUKIN-12 IMMUNOTHERAPY ON ENDOGENOUS SECRETION OF INTERLEUKIN-2 IN METASTATIC CANCER-PATIENTS, International journal of immunotherapy, 14(2), 1998, pp. 101-104
MELATONIN AS A NEW POSSIBLE ANTIINFLAMMATORY AGENT
Authors: LISSONI P ROVELLI F MEREGALLI S FUMAGALLI L MUSCO F BRIVIO F BRIVIO O ESPOSTI G
Citation: P. Lissoni et al., MELATONIN AS A NEW POSSIBLE ANTIINFLAMMATORY AGENT, Journal of biological regulators and homeostatic agents, 11(4), 1997, pp. 157-159
PROGNOSTIC-SIGNIFICANCE OF CHANGES IN IL-12 SECRETION DURING CANCER-IMMUNOTHERAPY WITH IL-2 - PRELIMINARY CONSIDERATIONS
Authors: LISSONI P FUMAGALLI L DIFELICE G MENGO S MAURI E MERLINI D MEREGALLI S ROVELLI F BARNI S TANCINI G
Citation: P. Lissoni et al., PROGNOSTIC-SIGNIFICANCE OF CHANGES IN IL-12 SECRETION DURING CANCER-IMMUNOTHERAPY WITH IL-2 - PRELIMINARY CONSIDERATIONS, International journal of immunotherapy, 13(1-2), 1997, pp. 17-23
ADJUVANT THERAPY WITH THE PINEAL HORMONE MELATONIN IN PATIENTS WITH LYMPH-NODE RELAPSE DUE TO MALIGNANT-MELANOMA
Authors: LISSONI P BRIVIO O BRIVIO F BARNI S TANCINI G CRIPPA D MEREGALLI S
Citation: P. Lissoni et al., ADJUVANT THERAPY WITH THE PINEAL HORMONE MELATONIN IN PATIENTS WITH LYMPH-NODE RELAPSE DUE TO MALIGNANT-MELANOMA, Journal of pineal research, 21(4), 1996, pp. 239-242
CORRELATION BETWEEN IL-12 AND IL-2 BLOOD-LEVELS IN THE METASTATIC NEOPLASTIC DISEASE - A POSSIBLE INHIBITORY FEEDBACK-SYSTEM REGULATING THEIR SECRETION
Authors: LISSONI P ROVELLI F GIANI L FUMAGALLI L MEREGALLI S COMI G MERLINI D
Citation: P. Lissoni et al., CORRELATION BETWEEN IL-12 AND IL-2 BLOOD-LEVELS IN THE METASTATIC NEOPLASTIC DISEASE - A POSSIBLE INHIBITORY FEEDBACK-SYSTEM REGULATING THEIR SECRETION, Journal of biological regulators and homeostatic agents, 10(4), 1996, pp. 92-94
INCREASED SURVIVAL-TIME IN BRAIN GLIOBLASTOMAS BY A RADIONEUROENDOCRINE STRATEGY WITH RADIOTHERAPY PLUS MELATONIN COMPARED TO RADIOTHERAPY ALONE
Authors: LISSONI P MEREGALLI S NOSETTO L BARNI S TANCINI G FOSSATI V MAESTRONI G
Citation: P. Lissoni et al., INCREASED SURVIVAL-TIME IN BRAIN GLIOBLASTOMAS BY A RADIONEUROENDOCRINE STRATEGY WITH RADIOTHERAPY PLUS MELATONIN COMPARED TO RADIOTHERAPY ALONE, Oncology, 53(1), 1996, pp. 43-46
A RANDOMIZED STUDY OF TAMOXIFEN ALONE VERSUS TAMOXIFEN PLUS MELATONININ ESTROGEN RECEPTOR-NEGATIVE HEAVILY PRETREATED METASTATIC BREAST-CANCER PATIENTS
Authors: LISSONI P ARDIZZOIA A BARNI S PAOLOROSSI F TANCINI G MEREGALLI S ESPOSTI D ZUBELEWICZ B BRACZOWSKI R
Citation: P. Lissoni et al., A RANDOMIZED STUDY OF TAMOXIFEN ALONE VERSUS TAMOXIFEN PLUS MELATONININ ESTROGEN RECEPTOR-NEGATIVE HEAVILY PRETREATED METASTATIC BREAST-CANCER PATIENTS, Oncology Reports, 2(5), 1995, pp. 871-873
A RANDOMIZED STUDY OF LOW-DOSE SUBCUTANEOUS INTERLEUKIN-2 PLUS MELATONIN VERSUS SUPPORTIVE CARE ALONE IN METASTATIC COLORECTAL-CANCER PATIENTS PROGRESSING UNDER 5-FLUOROURACIL AND FOLATES
Authors: BARNI S LISSONI P CAZZANIGA M ARDIZZOIA A MEREGALLI S FOSSATI V FUMAGALLI L BRIVIO F TANCINI G
Citation: S. Barni et al., A RANDOMIZED STUDY OF LOW-DOSE SUBCUTANEOUS INTERLEUKIN-2 PLUS MELATONIN VERSUS SUPPORTIVE CARE ALONE IN METASTATIC COLORECTAL-CANCER PATIENTS PROGRESSING UNDER 5-FLUOROURACIL AND FOLATES, Oncology, 52(3), 1995, pp. 243-245
MODULATION OF CANCER ENDOCRINE THERAPY BY MELATONIN - A PHASE-II STUDY OF TAMOXIFEN PLUS MELATONIN IN METASTATIC BREAST-CANCER PATIENTS PROGRESSING UNDER TAMOXIFEN ALONE
Authors: LISSONI P BARNI S MEREGALLI S FOSSATI V CAZZANIGA M ESPOSTI D TANCINI G
Citation: P. Lissoni et al., MODULATION OF CANCER ENDOCRINE THERAPY BY MELATONIN - A PHASE-II STUDY OF TAMOXIFEN PLUS MELATONIN IN METASTATIC BREAST-CANCER PATIENTS PROGRESSING UNDER TAMOXIFEN ALONE, British Journal of Cancer, 71(4), 1995, pp. 854-856
A CLINICAL-STUDY OF IMMUNOTHERAPY VERSUS ENDOCRINE THERAPY VERSUS CHEMOTHERAPY IN THE TREATMENT OF ADVANCED PANCREATIC ADENOCARCINOMA
Authors: LISSONI P ARDIZZOIA A MEREGALLI S BARNI S FOSSATI V BRIVIO F TANCINI G
Citation: P. Lissoni et al., A CLINICAL-STUDY OF IMMUNOTHERAPY VERSUS ENDOCRINE THERAPY VERSUS CHEMOTHERAPY IN THE TREATMENT OF ADVANCED PANCREATIC ADENOCARCINOMA, Oncology Reports, 1(6), 1994, pp. 1277-1280
A RANDOMIZED STUDY OF IMMUNOTHERAPY WITH LOW-DOSE SUBCUTANEOUS INTERLEUKIN-2 PLUS MELATONIN VS CHEMOTHERAPY WITH CISPLATIN AND ETOPOSIDE CISPLATIN AND ETOPOSIDE AS FIRST-LINE
Authors: LISSONI P MEREGALLI S FOSSATI V PAOLOROSSI F BARNI S TANCINI G FRIGERIO F
Citation: P. Lissoni et al., A RANDOMIZED STUDY OF IMMUNOTHERAPY WITH LOW-DOSE SUBCUTANEOUS INTERLEUKIN-2 PLUS MELATONIN VS CHEMOTHERAPY WITH CISPLATIN AND ETOPOSIDE CISPLATIN AND ETOPOSIDE AS FIRST-LINE, Tumori, 80(6), 1994, pp. 464-467
RADIOENDOCRINE THERAPY OF BRAIN-TUMORS WITH THE LONG-ACTING OPIOID ANTAGONIST NALTREXONE IN ASSOCIATION WITH RADIOTHERAPY
Authors: LISSONI P MEREGALLI S FOSSATI V BARNI S TANCINI G BARIGOZZI P FRIGERIO F
Citation: P. Lissoni et al., RADIOENDOCRINE THERAPY OF BRAIN-TUMORS WITH THE LONG-ACTING OPIOID ANTAGONIST NALTREXONE IN ASSOCIATION WITH RADIOTHERAPY, Tumori, 79(3), 1993, pp. 198-201
Risultati: 1-15 |